Oneview Healthcare PLC [ASX:ONE] is a software and solutions company that provides interactive healthcare technologies for patients, families, and caregivers. It focuses on the development and sale of software for the healthcare sector and the provision of related consultancy services.
The ONE share price was up 58% to 8 cents at the time of writing, Oneview has made some exciting announcements in conjunction with the global pandemic of COVID-19.
Oneview has officially launched a cloud-based tablet solution to help healthcare systems and providers better manage hospitalised patients during and after the COVID-19 crisis.
Oneview Cloud for COVID-19 enables virtual rounds, virtual visitations (allowing patients to call friends and family), and virtual interpretation services. The tablet also provides patients with up-to-date information on COVID-19, as well as education and entertainment content. The first deployment of the new product is underway, with NYU Langone Health.
Oneview, New York, and COVID-19
New York is being hit the hardest by the novel COVID-19 spreading across the US, with more cases and more related deaths per capita than any other state.
The workload in hospitals having increased hugely requires new solutions for doctors and nurses so they are able to manage the influx of patients.
Oneview CEO James Fitter commented:
‘Healthcare organisations are having to rapidly adapt now to ensure they can deploy critical resources where they are needed the most and one of the big changes is to the daily “rounds” to monitor patients.’
The future of the ONE share price
Holding a market cap of $8.66 million, the company continued to acquire new customers in 2019 both here in Australia and the US.
Confidence is being shown in the company, having substantial holders come on board as recently as 31 March.
The chart above is showing historic resistance levels of 10 cents, 15 cents, and 20 cents. The novel COVID-19 virus has presented an opportunity for Oneview. Hospitals are in need of technology to monitor and communicate with patients now more than ever.
With no end in sight for the pandemic, this may well be an opportune time for growth in price.
If you are looking to protect your money during the ‘corona crisis’, check out this free report by our Money Morning analyst, where he reveals a two-pronged plan to help you deal with the financial implications of COVID-19. Download your free report here.
For Money Morning